TARDBP and amyotrophic lateral sclerosis: Furthermore, plasma EV TDP-43 levels were more strongly associated with these clinical variables than were plasma neurofilament light levels (currently the leading prognostic biomarker for ALS), indicating that EV TDP-43 levels are not simply a reflection of the rate of axonal loss (r = -0.29 and -0.37 respectively).